2016-02-15 08:46:06 CET
2016-02-15 08:46:06 CET
REGULATED INFORMATION
Raisio - Financial Statement Release
Raisio plc, Financial statements bulletin 2015
Raisio plc Financial Statements Bulletin 15 February 2016
RAISIO PLC, FINANCIAL STATEMENTS BULLETIN 2015
January-December 2015 excluding one-off items
-- The Group’s EBIT excluding one-off items improved by 48% and was EUR 51.7
million (EUR 34.8 million in 2014) accounting for 9.9% (7.0%) of net sales.
-- The Brands Division’s EBIT excluding one-off items was EUR 55.4 million
(EUR 35.9 million) accounting for 14.4% (11.7%) of net sales.
-- Raisioagro’s EBIT excluding one-off items was EUR 2.8 million (EUR 3.4
million).
-- The Group’s net sales totalled EUR 521.2 million (EUR 493.9 million).
-- Cash flow from operations was EUR 65.0 million (EUR 26.2 million)
-- The Board’s dividend proposal is EUR 0.16 (EUR 0.14) per share, +14%.
October-December 2015 excluding one-off items
-- The Group’s EBIT excluding one-off items was EUR 12.0 million (Q4/2014: EUR
8.9 million), accounting for 9.8% (7.6%) of net sales.
-- The Brands Division’s EBIT excluding one-off items was EUR 13.9 million
(EUR 10.6 million), accounting for 14.3% (12.5%) of net sales.
-- Raisioagro’s EBIT excluding one-off items was EUR 0.0 million (EUR 0.0
million).
-- The Group’s net sales totalled EUR 122.7 million (EUR 117.8 million).
Raisio Group’s key figures
Q4 Q4/ Q3/ Q2/ Q1 2015 2014
2015 2014 2015 2015 2015
--------------------------------------------------------------------------------
Result
--------------------------------------------------------------------------------
Net sales M€ 122.7 117.8 134.5 141.5 122.5 521.2 493.9
--------------------------------------------------------------------------------
Change in net sales % 4.2 -10.2 5.9 6.8 5.0 5.5 -11.4
--------------------------------------------------------------------------------
EBIT M€ 5.7 -7.2 16.0 11.1 9.6 42.4 6.9
--------------------------------------------------------------------------------
EBIT, excluding one-off M€ 12.0 8.9 16.0 14.0 9.6 51.7 34.8
items
--------------------------------------------------------------------------------
EBIT, excluding one-off % 9.8 7.6 11.9 9.9 7.9 9.9 7.0
items
--------------------------------------------------------------------------------
Depreciation and M€ 7.1 15.4 3.5 6.9 3.6 21.1 32.9
impairment
--------------------------------------------------------------------------------
Depreciation and M€ 3.5 3.4 3.5 5.9 3.6 16.5 14.6
impairment, excluding
one-off items
--------------------------------------------------------------------------------
EBITDA M€ 12.8 8.3 19.5 18.0 13.2 63.6 39.8
--------------------------------------------------------------------------------
EBITDA M€ 15.4 12.3 19.5 20.0 13.2 68.1 49.5
excluding one-off items
--------------------------------------------------------------------------------
Financial items M€ -1.0 -1.0 -0.7 -0.4 -0.5 -2.5 -1.5
--------------------------------------------------------------------------------
Earnings per share (EPS) € 0.04 -0.04 0.08 0.05 0.05 0.22 0.04
--------------------------------------------------------------------------------
Earnings per share (EPS) € 0.06 0.05 0.08 0.07 0.05 0.26 0.18
excluding one-off items
--------------------------------------------------------------------------------
Balance sheet
--------------------------------------------------------------------------------
Equity ratio % - - - - - 62.3 60.2
--------------------------------------------------------------------------------
Gearing % - - - - 12.1 22.2
--------------------------------------------------------------------------------
Net interest-bearing M€ - - - - - 42.2 72.2
debt
--------------------------------------------------------------------------------
Equity per share € - - - - - 2.23 2.07
--------------------------------------------------------------------------------
Dividend per share € - - - - - 0.16* 0.14
--------------------------------------------------------------------------------
Investments** M€ 3.3 90.7 2.6 3.0 2.1 11.0 104.9
--------------------------------------------------------------------------------
* Board of Directors’ proposal to the Annual General Meeting
** Including acquisitions
Figures for the comparison period are given in brackets. The financial
statements review has not been audited.
CHIEF EXECUTIVE’S REVIEW FOR 2015
“Raisio achieved EBIT of EUR 51.7 million excluding one-off items in 2015. At
the same time, the Group’s EBIT margin excluding one-off items rose to 9.9 per
cent. EBIT improved by nearly 17 million euros and EBIT margin by almost three
percentage points, which is a strong performance in a difficult market
situation.
Good results together with efficient net working capital management ensured
operating cash flow of EUR 65 million.
The key factor in Raisio’s profit improvement was the acquisition of Benecol
consumer product business in the UK, Ireland and Belgium in November 2014. The
largest market for Benecol products is the UK, where Raisio increased its
marketing efforts according to plan and, as a result, Benecol product sales
turned into organic growth. The growth is expected to continue this year.
At the end of 2015, Benemilk had its first Primafat order. Benemilk is no
longer a pre-revenue company. In addition, the first patents were obtained in
2015."
OUTLOOK 2016
Despite the weakened visibility and difficult market conditions, Raisio expects
its EBIT to improve in 2016.
RAISIO PLC
Heidi Hirvonen
Communications and IR Manager
tel. +358 50 567 3060
Further information:
Matti Rihko, CEO, tel. +358 400 830 727
Antti Elevuori, CFO, tel. +358 40 560 4148
Heidi Hirvonen, Communications and IR Manager, tel. +358 50 567 3060
Raisio’s financial reviews in 2016
-- Raisio’s Online Annual Report 2015 will be published in week 10 at
www.raisio.com
-- Interim Report January-March on 10 May 2016
-- Interim Report January-June on 10 August 2016
-- Interim Report January-September on 9 November 2016
Raisio plc
Raisio plc is an international specialist in plant-based nutrition. Raisio’s
operations are divided into two divisions: Brands and Raisioagro. The Group’s
key market areas are Finland, Great Britain, the Czech Republic, Russia and
Poland. Markets for cholesterol lowering Benecol products are global. Raisio
plc’s shares are listed on Nasdaq Helsinki Ltd. Raisio’s turnover in 2015 was
EUR 521 million. The Group employs some 1,800 people. Raisio’s best-known
brands are Benecol, Benemilk, Elovena Honey Monster, Fox’s and Poppets.
Benemilk feeds for milk production and Benecol for cholesterol lowering are
Raisio’s top innovations. For more information on Raisio go to
www.raisio.com/en
Distribution
Nasdaq
Key media
www.raisio.com
© 2024 Nasdaq, Inc. All Rights Reserved |